Are serotonergic system genes associated to smoking cessation therapy success in addition to CYP2A6?
Verde, Z
Are serotonergic system genes associated to smoking cessation therapy success in addition to CYP2A6? [electronic resource] - Pharmacopsychiatry Jan 2014 - 33-6 p. digital
Publication Type: Letter; Research Support, Non-U.S. Gov't
1439-0795
10.1055/s-0033-1358393 doi
Adult
Aryl Hydrocarbon Hydroxylases--genetics
Bupropion--therapeutic use
Cytochrome P-450 CYP2A6
Dopamine Uptake Inhibitors--therapeutic use
Female
Genetic Association Studies
Genotype
Humans
Male
Middle Aged
Nicotine--therapeutic use
Nicotinic Agonists--therapeutic use
Pharmacogenetics
Polymorphism, Genetic--genetics
Receptor, Serotonin, 5-HT2A--genetics
Serotonin Plasma Membrane Transport Proteins--genetics
Smoking Cessation
Tobacco Use Disorder--genetics
Are serotonergic system genes associated to smoking cessation therapy success in addition to CYP2A6? [electronic resource] - Pharmacopsychiatry Jan 2014 - 33-6 p. digital
Publication Type: Letter; Research Support, Non-U.S. Gov't
1439-0795
10.1055/s-0033-1358393 doi
Adult
Aryl Hydrocarbon Hydroxylases--genetics
Bupropion--therapeutic use
Cytochrome P-450 CYP2A6
Dopamine Uptake Inhibitors--therapeutic use
Female
Genetic Association Studies
Genotype
Humans
Male
Middle Aged
Nicotine--therapeutic use
Nicotinic Agonists--therapeutic use
Pharmacogenetics
Polymorphism, Genetic--genetics
Receptor, Serotonin, 5-HT2A--genetics
Serotonin Plasma Membrane Transport Proteins--genetics
Smoking Cessation
Tobacco Use Disorder--genetics